Safety and Tolerability of 28 Days Treatment With Glycopyrrolate(NVA237) (100 or 200µg Once a Day) in Patients With Moderate to Severe COPD

This study has been completed.

Study NCT00510510 Information provided by Novartis

First Received: August 1, 2007 Last Updated: January 15, 2008 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Study Completion Date:	January 2008
Estimated Primary Completion Date:	No date given